Starling Oncology Inc. Wt
STLNW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.37M
Close$
$-5.97
26062.2% downside
Current Fair Value
26062.2% downsideOvervalued by 26062.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.37 Million |
|---|---|
| Enterprise Value | $67.91 Million |
| Earnings per Share | $-0.54 |
| Beta | 2.81 |
| Outstanding Shares | 103,031,493 |
Return
| Return on Equity | 145.67% |
|---|---|
| Return on Assets | -20.36% |
| Return on Invested Capital | -35.30% |
Valuation & Multiples
| P/E Ratio | -22.1 |
|---|---|
| PEG | 52.06 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.02 |
| Enterprise Value to Revenue | 0.12 |
| Enterprise Value to EBIT | -2.31 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.57 |
| Debt to Equity | -4.28 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.06
Consensus analyst estimateRevenue Estimate
$155.74 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.05
Consensus analyst estimateRevenue Estimate
$168.68 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About DFP Healthcare Acquisitions Corp
641 employees
CEO: Daniel Virnich
DFP Healthcare Acquisitions Corp. is a blank check company. The Company’s business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more ...